Radioimmunoimaging diagnosis of ovarian benign and malignant lesions of.doc

 PAGE \* MERGEFORMAT 17 Radioimmunoimaging diagnosis of ovarian benign and malignant lesions of [Abstract] Objective: To evaluate the ovarian benign and malignant lesions radioimmunoimaging law and in the ovarian cancer diagnosis, treatment, Value. Methods: 131I-CEA McAb radioimmunoimaging (R Ⅱ) diagnosed 44 cases to be diagnosed as ovarian cancer patients, the use of Y-scintigraphy supplemented by computer processing technology and dual-isotope subtraction technique. Results: After surgery and pathology confirmed 32 cases of ovarian cancer in 31 patients with positive imaging, and 1 case negative imaging (false negative), 9 patients with benign lesions have all been negative imaging and confirmed by surgery. 28/31 patients with positive imaging of ovarian cancer staging and surgical staging R Ⅱ a perfect match. 91 metastasis was found 86, the positive rate of 94.5%, the smallest detectable lesion diameter of ≥ 1cm. Conclusion: The method has been applied in the qualitative diagnosis of lesions while row Direct display lesion location, shape, size and quantity, for early detection of ovarian cancer, to guide the development of clinical staging and treatment of side Case, and the estimated prognosis have a high clinical value. [Keywords:] radioimmunoimaging surgery; ovarian cancer; diagnosis, radioisotope [Paper] epithelial ovarian cancer (ovarian epithelial cancer, OEC) is a common gynecologic malignancy, due to difficulties in early diagnosis, spread quickly, and thus a high mortality rate [1]. We used radionuclide 131 Ⅰ labeled carcinoembryonic antigen monoclonal antibody C50 (131 Ⅰ-CEA McAb) to be of clinical diagnosis of patients with OEC Radioimmunoimaging to explore the laws of its imaging and in ovarian cancer diagnosis and treatment of the clinical value of . 1, data and methods 1.1 Clinical data 1.1.1 The clinical diagnosis of ovarian cancer to be 44 cases selected from the Shandon